Statements (24)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
Controlled substance schedule
|
| gptkbp:administeredBy |
gptkb:Drug_Enforcement_Administration
|
| gptkbp:criteria |
No currently accepted medical use in treatment in the United States
High potential for abuse Lack of accepted safety for use under medical supervision |
| gptkbp:dateEnacted |
1970
|
| gptkbp:enactedBy |
gptkb:United_States_Congress
|
| gptkbp:example |
gptkb:Heroin
gptkb:Methaqualone gptkb:Psilocybin gptkb:MDMA LSD Cannabis Peyote |
| https://www.w3.org/2000/01/rdf-schema#label |
Schedule I in United States
|
| gptkbp:jurisdiction |
gptkb:United_States
|
| gptkbp:legalStatus |
Illegal to manufacture, possess, or distribute except for research
|
| gptkbp:partOf |
gptkb:Controlled_Substances_Act
|
| gptkbp:relatedTo |
Schedule II in United States
Schedule III in United States Schedule IV in United States Schedule V in United States |
| gptkbp:bfsParent |
gptkb:methoxetamine
|
| gptkbp:bfsLayer |
7
|